Treatment of Mild Graves' Orbitopathy with Exophthalmos and Minor Lid Retraction
This protocol applies to patients with Graves' orbitopathy whose orbital features — including exophthalmos and minor lid changes — have only a limited impact on daily life, making watchful management and local measures the appropriate first step rather than immunomodulation or surgery.
Clinical Scenario
- Classified as mild Graves' orbitopathy
- Minor lid retraction (<2 mm)
- Mild soft-tissue involvement
- Exophthalmos <3 mm above normal for race and gender
- No or intermittent diplopia
- Corneal exposure responsive to lubricants
Treatment Approach
Management at this stage focuses on local ocular protective measures and control of modifiable risk factors. For patients with mild, active disease of recent onset, a defined course of selenium supplementation is included in the evidence-based approach.
Full sequenced regimen available via the protocol…
References
DOI: 10.1530/EJE-21-0479
- Patients whose features of GO have only a minor impact on daily life that have insufficient impact to justify immunomodulation or surgical treatment.
- Minor lid retraction (<2 mm)
- Mild soft-tissue involvement
- Exophthalmos <3 mm above normal for race and gender
- No or intermittent diplopia and corneal exposure responsive to lubricants
- Mild GO should be treated with local treatments and general measures to control risk factors; a 6-month selenium supplementation should be given to patients with mild and active GO of recent onset, because it improves eye manifestations and QoL and usually prevents GO progression to more severe forms.
- All patients with GO should be extensively treated locally with artificial tears at all times in the course of their disease unless corneal exposure requires higher protection than ophthalmic gels or ointment, especially at nighttime.
- Therefore, a watchful strategy and local treatments are sufficient.
View source ↗